Compare · STE vs YDDL
STE vs YDDL
Side-by-side comparison of STERIS plc (Ireland) (STE) and One and One Green Technologies. Inc (YDDL): market cap, price performance, sector, and recent activity on the wire.
Summary
- STE operates in Health Care, while YDDL operates in Consumer Discretionary - the two are in different parts of the market.
- STE is the larger of the two at $20.50B, about 146.3x YDDL ($140.1M).
- Over the past year, STE is down 12.5% and YDDL is down 52.3% - STE leads by 39.8 points.
- STE has been more active in the news (39 items in the past 4 weeks vs 4 for YDDL).
- STE has more recent analyst coverage (16 ratings vs 0 for YDDL).
- Company
- STERIS plc (Ireland)
- One and One Green Technologies. Inc
- Price
- $212.40+1.12%
- $2.65+6.65%
- Market cap
- $20.50B
- $140.1M
- 1M return
- +2.45%
- -38.56%
- 1Y return
- -12.51%
- -52.34%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- 2025
- News (4w)
- 39
- 4
- Recent ratings
- 16
- 0
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest STE
- Sr. VP, Gen Counsel, and Sec. Zangerle John Adam covered exercise/tax liability with 401 units of Ordinary Shares, decreasing direct ownership by 1% to 36,678 units (SEC Form 4)
- V.P. & Corporate Treasurer Tamaro Renato covered exercise/tax liability with 65 units of Ordinary Shares, decreasing direct ownership by 1% to 6,194 units (SEC Form 4)
- Sr. VP and GM, Life Sciences Madsen Julia covered exercise/tax liability with 195 units of Ordinary Shares, decreasing direct ownership by 2% to 12,257 units (SEC Form 4)
- SVP & GM, AST Kohler Kenneth E covered exercise/tax liability with 150 units of Ordinary Shares, decreasing direct ownership by 1% to 11,332 units (SEC Form 4)
- SVP & Chief HRO Fraser Mary Clare covered exercise/tax liability with 600 units of Ordinary Shares, decreasing direct ownership by 4% to 13,716 units (SEC Form 4)
- President and CEO Carestio Daniel A covered exercise/tax liability with 1,889 units of Ordinary Shares and sold $946,799 worth of Ordinary Shares (4,428 units at $213.82), decreasing direct ownership by 9% to 63,647 units (SEC Form 4)
- Sr. Vice Pres., CFO Burton Karen L covered exercise/tax liability with 90 units of Ordinary Shares, decreasing direct ownership by 0.68% to 13,184 units (SEC Form 4)
- Sr. VP, Gen Counsel, and Sec. Zangerle John Adam covered exercise/tax liability with 365 units of Ordinary Shares, decreasing direct ownership by 0.97% to 37,079 units (SEC Form 4)
- V.P. & Corporate Treasurer Tamaro Renato covered exercise/tax liability with 64 units of Ordinary Shares, decreasing direct ownership by 1% to 6,259 units (SEC Form 4)
- Sr. VP and GM, Life Sciences Madsen Julia covered exercise/tax liability with 239 units of Ordinary Shares, decreasing direct ownership by 2% to 12,452 units (SEC Form 4)
Latest YDDL
- One and One Green Technologies. INC Plans to Commission In-House Chemical Testing Laboratory at Philippine Facility, Supporting Vertical Quality Control Across Recycling Operations
- SEC Form EFFECT filed by One and One Green Technologies. Inc
- One and One Green Technologies. INC Signs Smelting Equipment Contract to Support Electronic, Copper, and Nickel Sludge Recovery Lines with Production Targeted for Second Half of 2026
- SEC Form F-1 filed by One and One Green Technologies. Inc
- One and One Green Technologies Reports Strong 2025 Financial Results With 82% Increase in Net Income
- SEC Form 20-F filed by One and One Green Technologies. Inc
- SEC Form 6-K filed by One and One Green Technologies. Inc
- One and One Green Technologies. INC to Report Fiscal Year 2025 Financial Results and Hold Earnings Call on April 28, 2026
- Edison Initiates Coverage on One and One Green Technologies with a US$8.3 Base Case Valuation
- SEC Form 6-K filed by One and One Green Technologies. Inc